Literature DB >> 11964286

A functional role of Stat3 in in vivo megakaryopoiesis.

Keita Kirito1, Masatake Osawa, Haruhiko Morita, Ritsuko Shimizu, Masayuki Yamamoto, Atsushi Oda, Hiroyoshi Fujita, Masaru Tanaka, Koichi Nakajima, Yasusada Miura, Keiya Ozawa, Norio Komatsu.   

Abstract

The signal transducer and activator of transcription 3 (Stat3), a member of the Stat family of proteins, is commonly activated by thrombopoietic cytokines including thrombopoietin (TPO), interleukin (IL)-6, and interleukin-11. This finding strongly suggested that Stat3 has an important role in megakaryopoiesis and thrombopoiesis. To clarify the functional role of Stat3 in in vivo megakaryopoiesis and thrombopoiesis, we generated transgenic mice overexpressing a dominant-negative Stat3, Stat3F, to suppress the function of endogenous Stat3. To accomplish the selective expression of Stat3F in megakaryocytic lineage cells, we used the regulatory gene region of GATA-1 transcription factor selectively expressed in megakaryocytic and erythroid lineage cells. Two independent transgenic (Tg) mice lines were established. It was confirmed by Western blotting analysis that Stat3F proteins were highly expressed in the platelets from the Tg mice. In addition, it was found that Stat3 activation induced by TPO stimulation was drastically suppressed in these Tg mice compared with littermates. These findings indicate that Stat3F works well in the Tg mice. Platelet counts were within the normal range in steady-state conditions and were recovered normally from transient thrombocytopenia induced by antiplatelet serum injection. Interestingly, the platelet recovery from myelosuppression after 5-fluorouracil treatment was significantly delayed in the Tg mice. Collectively, our results strongly suggest that Stat3 plays an important role in the early stage of megakaryopoiesis, presumably through the expansion of megakaryocytic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964286     DOI: 10.1182/blood.v99.9.3220

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  24 in total

1.  Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.

Authors:  Kellie R Machlus; Stephen K Wu; Prakrith Vijey; Thomas S Soussou; Zhi-Jian Liu; Eran Shacham; T J Unger; Trinayan Kashyap; Boris Klebanov; Martha Sola-Visner; Marsha Crochiere; Joseph E Italiano; Yosef Landesman
Journal:  Blood       Date:  2017-06-19       Impact factor: 22.113

2.  Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation.

Authors:  Christian A Di Buduo; Manuela Currao; Alessandro Pecci; David L Kaplan; Carlo L Balduini; Alessandra Balduini
Journal:  Haematologica       Date:  2016-08-11       Impact factor: 9.941

3.  Estrogen promotes megakaryocyte polyploidization via estrogen receptor beta-mediated transcription of GATA1.

Authors:  C Du; Y Xu; K Yang; S Chen; X Wang; S Wang; C Wang; M Shen; F Chen; M Chen; D Zeng; F Li; T Wang; F Wang; J Zhao; G Ai; T Cheng; Y Su; J Wang
Journal:  Leukemia       Date:  2016-10-17       Impact factor: 11.528

4.  Cytopenia induction by 5-fluorouracil identifies thrombopoietic mutants in sensitized ENU mutagenesis screens.

Authors:  Nicole M Anderson; Zorana Berberovic; Elizabeth Berndl; Monica L Bailey; Ann M Flenniken; Lucy R Osborne; S Lee Adamson; Janet Rossant; Chen Wang; Mark D Minden; Kelly M McNagny; Robert F Paulson; Dwayne L Barber; William L Stanford
Journal:  Exp Hematol       Date:  2011-09-14       Impact factor: 3.084

5.  The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia.

Authors:  Suzanne M Koopmans; Freek J Bot; Harry C Schouten; Jannie Janssen; Arienne Mw van Marion
Journal:  Am J Blood Res       Date:  2012-05-25

6.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

7.  Gender dependence for a subset of the low-abundance signaling proteome in human platelets.

Authors:  Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Stephen W Rothwell; David M Jacobowitz; Xiaoduo Ji; Xiuying Zhang; William Guggino; Jerry Wright; Jeffrey Kiefer; Cara Olsen; Nima Adimi; Gregory P Mueller; Harvey B Pollard
Journal:  Hum Genomics Proteomics       Date:  2010-04-13

8.  STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.

Authors:  Lucile Couronné; Laurianne Scourzic; Camilla Pilati; Véronique Della Valle; Yannis Duffourd; Eric Solary; William Vainchenker; Jean-Philippe Merlio; Marie Beylot-Barry; Frederik Damm; Marc-Henri Stern; Philippe Gaulard; Laurence Lamant; Eric Delabesse; Hélène Merle-Beral; Florence Nguyen-Khac; Michaëla Fontenay; Hervé Tilly; Christian Bastard; Jessica Zucman-Rossi; Olivier A Bernard; Thomas Mercher
Journal:  Haematologica       Date:  2013-07-19       Impact factor: 9.941

9.  STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

Authors:  Zan Huang; Terri D Richmond; Andrew G Muntean; Dwayne L Barber; Mitchell J Weiss; John D Crispino
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.

Authors:  Wei-Jing Gong; Li-Yun Ma; Lei Hu; Yong-Ning Lv; Hong Huang; Jia-Qiang Xu; Dan-Dan Huang; Rui-Jie Liu; Yong Han; Yu Zhang; Shao-Jun Shi; San-Lan Wu
Journal:  Int J Clin Oncol       Date:  2019-01-28       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.